XML 61 R39.htm IDEA: XBRL DOCUMENT v3.5.0.2
Restricted Net Assets (Tables)
12 Months Ended
Jun. 30, 2016
Restricted Net Assets [Abstract]  
Parent Company Condensed Balance Sheets

Condensed Balance Sheets As of June 30, 
  2016  2015 
ASSETS      
Current Assets:      
Cash and cash equivalents $167,495  $306,376 
Other current assets  70   2,977 
Total Current Assets  167,565   309,353 
         
Long-term equity investment  376,321,912   377,245,446 
Total long term assets  376,321,912   377,245,446 
Total Assets $376,489,477  $377,554,799 
         
LIABILITIES AND STOCKHOLDERS' EQUITY        
Current Liabilities:        
Accounts payable $214,520  $214,520 
Amount due to related parties  1,388,743   888,743 
Other payables and accrued expenses  4,401,882   3,502,062 
Total Current Liabilities  6,005,145   4,605,325 
         
Stockholders' Equity        
Common stock, $.001 par value, 115,197,165 shares authorized,   37,648,605 and 35,905,198, shares issued and outstanding as of June 30, 2016 and 2015, respectively  37,648   35,905 
Additional paid in capital  127,593,932   123,360,384 
Accumulated other comprehensive income  (5,696,388)  25,708,238 
Retained earnings  248,549,140   223,844,947 
Total Stockholders' Equity  370,484,332   372,949,474 
Total Liabilities and Stockholders' Equity $376,489,477  $377,554,799
Parent Company Condensed Statements of Operations

Condensed Statements of Operations Year ended June 30, 
  2016  2015 
Revenue $-  $- 
General and administrative expenses  5,768,770   

6,560,980

 
Interest income  30   200 
Equity investment in subsidiaries  30,472,933   38,005,906 
Net income $24,704,193  $

31,445,126

Parent Company Condensed Statements of Cash Flows

Condensed Statements of Cash Flows Year Ended June 30, 
  2016  2015 
Net cash provided by (used in) operating activities $(138,881) $188,437 
Net cash provided by investing activities  -   - 
Net cash provided by financing activities  -   - 
Cash and cash equivalents, beginning balance  306,376   117,939 
Cash and cash equivalents, ending balance $167,495  $306,376